XML 130 R113.htm IDEA: XBRL DOCUMENT v3.24.0.1
Segments - Summary of Segment Profit (Detail) - USD ($)
$ in Millions
 3 Months Ended 12 Months Ended
Dec. 31, 2023
Sep. 30, 2023
Jun. 30, 2023
Mar. 31, 2023
Dec. 31, 2022
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Amounts Allocated To Segments [Abstract]                    
Consolidated operating income (loss)   $ 344 $ (654) $ (13) $ (940) $ 424 $ (967) $ 433 [1] $ (2,197) [1] $ 1,716 [1]
Amounts Not Allocated To Segments [Abstract]                    
Amortization               616 732 802
Other asset impairments, restructuring and other items   57 108 110 217 31 137 718 [1] 512 [1] 341 [1]
Goodwill impairment $ 0   700         700 2,045 0
Intangible assets impairments               350 355 424
Legal settlements and loss contingencies               1,043 2,082 717
Other Unallocated Amounts               502 610 402
Revenues               15,846 14,925 15,878
Gross profit               7,645 6,973 7,594
R&D expenses               953 838 967
S&M expenses               2,336 2,265 2,429
G&A expenses               1,162 1,180 1,099
Segment profit   344 (654) (13) (940) 424 (967) 433 [1] (2,197) [1] 1,716 [1]
Financial expenses, net               1,057 966 1,058
Consolidated income (loss) before income taxes   $ 64 $ (923) $ (272) $ (1,185) $ 171 $ (1,178) (624) [1],[2] (3,163) [1],[2] 658 [1],[2]
North America [Member]                    
Amounts Allocated To Segments [Abstract]                    
Consolidated operating income (loss)               2,396 1,993 2,224
Amounts Not Allocated To Segments [Abstract]                    
Revenues               8,124 7,452 7,809
Gross profit               4,421 3,926 4,226
R&D expenses               625 532 618
S&M expenses               1,005 941 988
G&A expenses               403 474 427
Other (income) expense               (8) (15) (31)
Segment profit               2,396 1,993 2,224
Europe [Member]                    
Amounts Allocated To Segments [Abstract]                    
Consolidated operating income (loss)               1,478 1,496 1,494
Amounts Not Allocated To Segments [Abstract]                    
Revenues               4,837 4,525 4,886
Gross profit               2,726 2,700 2,823
R&D expenses               220 213 244
S&M expenses               767 748 846
G&A expenses               263 246 244
Other (income) expense               (2) (3) (5)
Segment profit               1,478 1,496 1,494
International Markets [Member]                    
Amounts Allocated To Segments [Abstract]                    
Consolidated operating income (loss)               464 479 529
Amounts Not Allocated To Segments [Abstract]                    
Revenues               1,958 1,903 2,032
Gross profit               1,050 1,033 1,118
R&D expenses               83 72 68
S&M expenses               420 405 417
G&A expenses               118 119 109
Other (income) expense               (35) (43) (5)
Segment profit               464 479 529
Segments and Other Activities [Member]                    
Amounts Allocated To Segments [Abstract]                    
Consolidated operating income (loss)               4,361 4,139 4,401
Amounts Not Allocated To Segments [Abstract]                    
Segment profit               4,361 4,139 4,401
Other Segments [Member]                    
Amounts Allocated To Segments [Abstract]                    
Consolidated operating income (loss)               24 172 154
Amounts Not Allocated To Segments [Abstract]                    
Segment profit               24 172 154
Corporate Segment [Member]                    
Amounts Allocated To Segments [Abstract]                    
Consolidated operating income (loss)               4,338 3,968 4,246
Amounts Not Allocated To Segments [Abstract]                    
Segment profit               $ 4,338 $ 3,968 $ 4,246
[1] The data presented for 2022 have been revised to reflect a revision in relation to a contingent consideration liability and related expenses in the consolidated financial statements. See note 1b.
[2] The financial data presented in the tables above for the year ended December 31, 2022 have been revised as discussed in note 1b.